Cargando…

Amyloid PET, FDG-PET or MRI? - the power of different imaging biomarkers to detect progression of early Alzheimer’s disease

BACKGROUND: As investigations of disease modifying drugs aim to slow down progression of Alzheimer’ disease (AD) biomarkers to reliably track disease progression gain more importance. This is especially important as clinical symptoms, including psychometric measures, are only modestly associated wit...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ortner, Marion, Drost, René, Heddderich, Dennis, Goldhardt, Oliver, Müller-Sarnowski, Felix, Diehl-Schmid, Janine, Förstl, Hans, Yakushev, Igor, Grimmer, Timo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2019
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6822351/ https://www.ncbi.nlm.nih.gov/pubmed/31672138 http://dx.doi.org/10.1186/s12883-019-1498-9

Ejemplares similares

Correction to: Amyloid PET, FDG-PET or MRI? - the power of different imaging biomarkers to detect progression of early Alzheimer’s disease
por: Ortner, Marion, et al.
Publicado: (2020)

Regional Cerebral Associations Between Psychometric Tests and Imaging Biomarkers in Alzheimer’s Disease
por: Hedderich, Dennis M., et al.
Publicado: (2020)

The cerebrospinal fluid biomarker ratio Aβ42/40 identifies amyloid positron emission tomography positivity better than Aβ42 alone in a heterogeneous memory clinic cohort
por: Amft, Michaela, et al.
Publicado: (2022)

Elecsys Cerebrospinal Fluid Immunoassays Accurately Detect Alzheimer’s Disease Regardless of Concomitant Small Vessel Disease
por: Ortner, Marion, et al.
Publicado: (2023)

Kallikrein-related peptidases 6 and 10 are elevated in cerebrospinal fluid of patients with Alzheimer’s disease and associated with CSF-TAU and FDG-PET
por: Goldhardt, Oliver, et al.
Publicado: (2019)

Correction: (18)F-FIBT may expand PET for β-amyloid imaging in neurodegenerative diseases
por: Grimmer, Timo, et al.
Publicado: (2018)

Serum Concentrations of Cholinesterase Inhibitors in Patients With Alzheimer’s Dementia Are Frequently Below the Recommended Levels
por: Ortner, Marion, et al.
Publicado: (2020)

Therapeutic Drug Monitoring of Rivastigmine and Donepezil Under Consideration of CYP2D6 Genotype-Dependent Metabolism of Donepezil
por: Ortner, Marion, et al.
Publicado: (2020)

Cerebrospinal fluid lactate levels along the Alzheimer’s disease continuum and associations with blood-brain barrier integrity, age, cognition, and biomarkers
por: Zebhauser, Paul Theo, et al.
Publicado: (2022)

FDG-PET underscores the key role of the thalamus in frontotemporal lobar degeneration caused by C9ORF72 mutations
por: Diehl-Schmid, Janine, et al.
Publicado: (2019)

Mapping covariance in brain FDG uptake to structural connectivity
por: Yakushev, Igor, et al.
Publicado: (2021)

Cerebrospinal fluid biomarkers for Alzheimer’s disease: the role of apolipoprotein E genotype, age, and sex
por: Mehrabian, Shima, et al.
Publicado: (2015)

Reference Cluster Normalization Improves Detection of Frontotemporal Lobar Degeneration by Means of FDG-PET
por: Dukart, Juergen, et al.
Publicado: (2013)

FDG-PET hypermetabolism is associated with higher tau-PET in mild cognitive impairment at low amyloid-PET levels
por: Rubinski, Anna, et al.
Publicado: (2020)

Progressively Disrupted Intrinsic Functional Connectivity of Basolateral Amygdala in Very Early Alzheimer’s Disease
por: Ortner, Marion, et al.
Publicado: (2016)

Decreased Vascular Pulsatility in Alzheimer’s Disease Dementia Measured by Transcranial Color-Coded Duplex Sonography
por: Ortner, Marion, et al.
Publicado: (2019)

Dialysis Related Amyloid Arthropathy on (18)FDG PET-CT
por: Kecler-Pietrzyk, A, et al.
Publicado: (2014)

Clinical, FDG and amyloid PET imaging in posterior cortical atrophy
por: Singh, Tarun D., et al.
Publicado: (2015)

LRP-1 polymorphism is associated with global and regional amyloid load in Alzheimer's disease in humans in-vivo
por: Grimmer, Timo, et al.
Publicado: (2014)

FDG-PET versus Amyloid-PET Imaging for Diagnosis and Response Evaluation in Alzheimer’s Disease: Benefits and Pitfalls
por: Høilund-Carlsen, Poul F., et al.
Publicado: (2023)

A Survey of FDG- and Amyloid-PET Imaging in Dementia and GRADE Analysis
por: Daniela, Perani, et al.
Publicado: (2014)

FDG-PET and PET/CT - Part II
por: Takalkar, Amol M, et al.
Publicado: (2008)

FDG-PET in lymphoma
por: Meignan, Michel
Publicado: (2014)

PET-FDG: Impetus
por: Nanni, Cristina
Publicado: (2020)

Altered neurovascular coupling as measured by optical imaging: a biomarker for Alzheimer’s disease
por: Kotliar, Konstantin, et al.
Publicado: (2017)

Multimodality Imaging Approaches in Alzheimer's disease. Part II: 1H MR spectroscopy, FDG PET and Amyloid PET
por: Promteangtrong, Chetsadaporn, et al.
Publicado: (2015)

Erratum to “A Survey of FDG- and Amyloid-PET Imaging in Dementia and GRADE Analysis”
por: Perani, Daniela, et al.
Publicado: (2014)

Phantom criteria for qualification of brain FDG and amyloid PET across different cameras
por: Ikari, Yasuhiko, et al.
Publicado: (2016)

Predicting long‐term clinical stability in amyloid‐positive subjects by FDG‐PET
por: Iaccarino, Leonardo, et al.
Publicado: (2019)

FDG PET or PET/CT in Evaluation of Renal Angiomyolipoma
por: Lin, Chun-Yi, et al.
Publicado: (2013)

Regional uptakes from early-frame amyloid PET and (18)F-FDG PET scans are comparable independent of disease state
por: Myoraku, Alison, et al.
Publicado: (2022)

Within-patient correspondence of amyloid-β and intrinsic network connectivity in Alzheimer’s disease
por: Myers, Nicholas, et al.
Publicado: (2014)

FDG-PET in colorectal cancer
por: de Geus-Oei, Lioe-Fee, et al.
Publicado: (2006)

FDG-PET of Takayasu’s Arteritis
por: Shikino, Kiyoshi, et al.
Publicado: (2014)

FDG-PET/CT in lymphoma
por: D'souza, Maria M, et al.
Publicado: (2013)

FDG-PET and colon cancer
por: Miles, Ken
Publicado: (2015)

Reply to: FDG PET and PET/CT: EANM procedure guideline for tumour PET imaging
por: Boellaard, Ronald, et al.
Publicado: (2010)

FDG and Amyloid PET in Cognitively Normal Individuals at Risk for Late-Onset Alzheimer’s Disease
por: Murray, John, et al.
Publicado: (2014)

Visualization of Dialysis-Related Amyloid Arthropathy on (18)F-FDG PET-CT Scan
por: Cheon, Miju, et al.
Publicado: (2022)

Detection of primary sites in unknown primary tumors using FDG-PET or FDG-PET/CT
por: Park, Jong Sun, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_eo9shubtl3adp927hk7hdn8lj3